Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ally Financial Inc (ALLY) vs DexCom, Inc. (DXCM) Price & Performance

Ally Financial IncTrade
DexCom, Inc.Trade

Price performance (Past 24H)

Key statistics

Ally Financial Inc vs DexCom, Inc. — how do they compare? Ally Financial Inc trades at $44.15 (market cap $13.32B), while DexCom, Inc. trades at $89.53 (market cap $33.08B). The key difference: DexCom, Inc. is far larger — about 2.5× Ally Financial Inc's market cap, and Ally Financial Inc pays a 2.74% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.

ALLYDXCM
Market Cap
$13.32B$33.08B
Sector
FinancialsHealth
52-Week High
$47.25$89.53
52-Week Low
$35.96$54.84
Dividend Yield
2.74%
Enterprise Value
$32.53B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ally Financial Inc

No Aura AI signal available yet.

DexCom, Inc.

DXCM trades at $84.75, up 2.08% today and near its 52-week high. The stock shows bullish technical momentum with strong earnings beats in recent quarters, including Q2 2026 EPS of $0.70 versus $0.61 expected. Revenue growth accelerated to 13% year-over-year in Q2 2026, driven by G7 system adoption and international expansion. Cash flow from operations improved to $1.44 billion in 2025, supporting financial flexibility.

Outlook remains positive with raised FY2026 guidance and 80% analyst buy ratings, though valuation multiples like P/E of 33.5 suggest premium pricing. Key risks include competitive pressures in glucose monitoring and reliance on reimbursement policies. The consensus price target of $88.65 implies modest upside from current levels.

Returns comparison

Trailing returns across standard periods

About Ally Financial Inc

Ally Financial Inc is a diversified financial services firm that services automotive dealers and their retail customers. The company operates as a financial holding company and a bank holding company. Its banking subsidiary, Ally Bank, caters to the direct banking market through Internet, mobile, and mail. The company reports four business segments including Automotive Finance operations, Insurance operations, Mortgage Finance operations and Corporate Finance operations.

Read more on ALLY

About DexCom, Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.

Read more on DXCM